CVE-2026-31231Cognee thru v0.4.0 contains a critical remote code execution vulnerability in its notebook cell execution API endpoint.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
Cognee thru v0.4.0 contains a critical remote code execution vulnerability in its notebook cell execution API endpoint. The endpoint is designed to execute arbitrary Python code provided by the user, but it does so using the unsafe exec() function without any sandboxing, validation, or security controls. An attacker can exploit this by sending a specially crafted POST request containing malicious Python code to the execution endpoint. This leads to arbitrary code execution on the Cognee server with the privileges of the server process, allowing complete compromise of the system.
- CVSS
- 9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-94
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/topoteretes/cognee
- https://www.notion.so/CVE-2026-31231-35d1e13931888178a963ef9efeb29113
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.